New York University Langone Medical Center; Perlmutter Cancer Center

New York, New York 10016

0 studies enrolling now · 3 studies all time

What they study most

Glioblastoma, Metastatic Pancreatic Adenocarcinoma, Metastatic Pancreatic Cancer, Urothelial Carcinoma

Studies at this site

• INO-5401 and INO-9012 Delivered by Electroporation (EP) in Combination With Cemiplimab (REGN2810) in Newly-Diagnosed Glioblastoma (GBM) — Running, not enrolling
• INO-5401 + INO-9012 in Combination With Atezolizumab in Locally Advanced Unresectable or Metastatic/Recurrent Urothelial Carcinoma — Completed
• A Multi-center Trial to Evaluate Multiple Regimens in Metastatic Pancreatic Cancer — Completed